Search filters

Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial

Image Image of a generic work. The text above it indicates that there is no free image of the work available, and that if you own one, you can click on the placeholder link to upload it.
Description scientific article
Author/s

author: Brigitte Dréno  Michele Spina  Pier Luigi Zinzani  Reinhard Dummer  Jan Walewski 

Publication date June 6, 2017
Language English
Country of origin
Wikipedia link
Copyright status
Missing/wrong data? Edit Wikidata item